hosted. watch tonight 930 eastern on c-span2. you can see this on our free mobile video up c-span now or online at c-span.org. ♪♪ >> c-span is your unfiltered view of government funded by these television companies and more including cox. >> homework can be hard but squatting in a diner for internetwork is even harder. that's why we provide lower income students access to affordable internet so homework can just be homework. cox connect to complete. >> cox along with his other television providers given front row seat to democracy. >> bring us this morning, as tara reported for the national. we were talking during the break a lot has happened during the

last 12 hours. update our viewers on this deal in the senate, what means for prescription drugs. late yesterr schumer and senator joe manchin entered a reconciliation deal that includes drug price reform including the ability for medicare to negotiate drug >> it includes expansion of generous obamacare subsidies for another three years, otherwise they would expire at the end of the year. it includess investments climate change now which was a big reversal for senator joe manchin for a while looking like healthcare only piece of legislation selects what's been happening the last few hours. things are still far from guaranteed but that's what's being discussed at this moment. >> your here to focus on this prescription drug component,

tell us what exactly is the language and what itxa means for who gets to benefits for this. >> three major components advocates have been focused on. one big thing that's a long timr democrat goal, it will allow the secretary for medicare to negotiate drug prices and medicare and part c and d and to clarify to viewers, part d is the drug benefit for medicare beneficiaries that covers drugs. part b it's a little more unique. asically covers the costf drugs that you couldn't give yourself they have to be administered by a physician. so what the secretary will do is list high-priced single force

drugs. the first year that these negotiations will be implemented will be 2026. eventually building up to 20 drugs over the course of a few years. i will say that piece of the plant was surprising. there was a draft, i don't want to say identical but very similar. another piece to this is the bill is passed with out of out-of-pocket costs for medicare beneficiaries. it will cap their drug costs at $2000 and it will implement inflation rebates. if a drug manufacturer raises the prices of their drugs, faster than inflation, they will have to pay the difference back

to the program. host: when it comes to the negotiation of drugs with medicare, has there been an analysis of what that will do for the cost of medicare? guest: the analysis that we do have is shown what should be car fried. it would save the government $280 billion. those are the kind of numbers that we have been primarily working with in terms of specific beneficiaries for the drug price negotiation, a piece of it, i would have to know which one you can negotiate so course is going to be ac as we go. there has been something out --

analysis for out-of-pocket costs. showing that about 850,000 would have benefited that paid more than $2000 for their drugs. these are kind of the impacts that we know so far of this legislation. host: we invite our viewers to join in. especially those on medicare and get your reaction. capping out-of-pocket expenses, negotiating prices, etc.. eastern central part of the country (202) 748-8000. mountain, specific (202) 748-8001. i want to share this headline with our viewers u.s. manufacturing groups run six-figure ad campaign asking congress about the latest drug

pricing guilt -- bill. this is paid for by these manufacturing companies. [video clip] >> want a lower drug cost? price controls are hidden taxes on manufacturers that harm innovation, competitive nests and new cures. that our manufacturer's ability to develop innovative cures to diseases. support access to lifesaving medicines and the manufacturing workers that deliver it. paid for by the national association of manufacturers. host:erin? guest: this is a familiar argument from the pharmaceutical lobby. this is something they have fought against for many years now. in terms of the impact on innovation, the congressional budget did estimate along with saving $288 billion, it will

also cause fewer drugs to be introduced over the next 30 years. this is something that the pharmaceutical lobby as routinely argued against when democrats brought forth a proposal like this. so it is no shock that they are going to be doing all that they can, la being all that they can. they are very powerful. this is why a deal, you know, there is no guarantee what is going to happen on the floor. i think it's very important for the democratic caucus to get together on this. they need every single vote. you know, i am sure they are on the phones and i'm sure things are being discussed behind closed doors. host: the congressional budget office at the impact of allowing

price negotiations could prevent medicines arriving over market over the next two years. at the same time you pointed out, the government is going to save $288 billion. guest: i was just double checking our numbers this morning. they updated it to 15 over the next two years. yes, you know, i think were also -- where republicans off warn you about the effect. this is a concern that has been raised a lot whenever that has been a proposal on negotiating drug prices or really doing anything to affect drug pricing in the market. host: let's go to dave in south carolina. dave, good morning. question or comment here? caller: good morning. i have a great-niece who is missing a lobe in one long.

she has to have steroid shots and has medication she takes too. the price for the medicine is destroying her family. they have nowhere to turn, they work so they don't qualify for assistance. and i want to know what is this legislation going to do for people like that? what are they supposed to do? what their children die because they can afford the medicine they need? good day. host: does this any -- address anybody outside of medicare? guest: sufferable we know is it's pretty minted to the medicare program. there were prior proposals that would have applied that negotiated price to the private market. but especially last year when this was all part of build back better there were concerns about whether it can go through the process. democrats are trying to use, that would require a simple

majority. it would raise a concern. this is limited to medicare. that is not to say they are not going to try to turn back in do things for the credit market. i hope that even the public not be on board with this proposal that is not to say they also have not been discussing this issue. drug pricing has been a concern for them. we will see where the discussion goes from here but, yes, the line is pretty limited. host: caller: alabama, go ahead. i am a medicare recipient and i am diabetic too. i have seen my costs double

almost. actually, one of the insulin pens because it got so ridiculous in price i was ashamed to even accepted. that might sound strange but anyway i'm grateful that somebody is trained to do something about it and joe manchin host: was very good. what are your out-of-pocket expenses like figure drugs? caller: because i do have the, not right now but it still runs out of my income. it is almost 10% of my income just in co-pays. guest: actually, i wanted to note you mentioned insulin. this is one of the bigger changes between what is being discussed now and what is in build back at her. inflation was called out in that

bill. there was a specific out-of-pocket cap for insulin that is now being dropped out. it is moving proposals to try to bring down the cost of insulin. it is now moving in a separate bill from senators holland and shaheen. there has been some reported concerns from other republicans. i do know they want to ensure this one through proper hearing process. yes, there were pieces that would have been directly impactful. host: kate, in ohio. walking to the conversation. caller: thank you. i have a comments actually. i am on medicare and i am taking a diabetic medication.

last month, it cost me $44 for a 30 day supply. this month it cost me $245 for a 30 days by and next month is going to be $243 a month until whenever. so when i asked why, i couldn't get a good answer from anybody. >> that is with the insurance that you have to pay. $245 this month. this is, this drug thing is really a scam. i don't think our washington, our congressmen are doing anything about it. i do think they care about we the people. good example, the family that has decided if they're going to eat or keep their child dressed. this is terrible, absolutely terrible. host: erin durkin. guest: that is very interesting

and i can see here your specific situation, i apologize to why your costs increased. i think this is certainly something that democrats are at least trying to address especially within out-of-pocket cost cap. it will be interesting to see it -- if drug price negotiations will exist in this area but this is certainly something that has been a concern is how much drug traces are impacted -- impacting seniors. host: bernie sanders called it week saying that it covers a limited number of drugs and it doesn't take effect until 2026. your reaction to that? what would you like to see instead? guest: this is also a familiar kind of risk in the caucus.

this is something we have seen as democrats over the year. proposals, ideas, sanders has been vocal about allowing medicare to negotiate and he had his own proposal that would have allowed for broader negotiations. as like that is the thing about bridging and keeping them all on board because they are going to need every single vote to get anything through this process. host: what did the republicans want to address? a situation not in the bill? guest: so republicans have expressed concern, senator mitch mcconnell and senator grassley actually had also released a

statement highlighting what he and senator wiseman had proposed no more bipartisan bills and just a reminder to myself about the details here. really would have gone over what they call the middleman. pbm, and so it seems there are some ideas that i could get some people from proceeds of the aisle to be even with that. there were really big difficulties getting some of his colleagues on board. yes, so, even looking at the separate bills for senator collins and senator shaheen. again, how much republicans will be given on that. it going to be interesting and

it democrats are managing to get this through or it did get through congress. it will also, it would be interesting to see if they are willing to come back to the table and discuss more negotiations. host: andy in kentucky, good morning. >> i remember back when president trump was trying to get the cost down and he was fighting you guys like crazy on the democratic side over there. you're making this so political i bet somebody would have to say something that tells you no one ever felt being in the middle. after that the democrats regained the house in 2018. 10 days after that, they stopped price of pfizer, 10% and all of

them have going up since then. i'm sure you all are in pfizer's pockets also. you know, this drug industry. host: is a journalist who works for the "washington journal". what did president trump to when it comes to lowering prescription checks? guest: i'm glad you raised this i saw post on twitter that said at least one of the things having to do with high prescription types for drug prices abroad. this is an interesting one because not the exact same proposal but similar ideas democratic proposals, it is for someone who is very loud on drug

prices. but, you know to the colors of the week getting anything done on this issue has not -- has been very difficult. keeping the democratic caucus together has been difficult on this. also bridging the divide from democrats and democrats for any kind of partisan solution on this which has been very difficult on this. even though both sides of the aisle have expressed concerns on the issue. host: how does it differ from the senate bill? guest: i assume you are referring to build back better act from last november. actually the drug pricing proposal had actually gotten to a pretty similar place to the interim drug negotiations, inflationary drug -- rebates. it looks very similar but it had

those additional revisions around insulin. in other piece that apparently the bill would close is i guess there was a concern about future press secretaries will they be able to come in and maybe refusing to negotiate or negotiate as peer judge. at this bill will close that loophole. so that kind of the key different things. obviously, he pushes so much. including health, climate, things like that. host: sicilia, lewisville, texas. caller: erin, this bill that you were talking about, you are asking a lot. couldn't understand why the lady

was talking about medicines going up. i know for a fact because my brother is in the hospital for a year last year. he has eight medications. one of his medications, we can only afford to buy 14 pills, one weeks worth because it was $700 for 14 pills. he had eight other medications to go with that. so he was sitting three -- spending $3000 a week. it's ridiculous. you all want all these medications out there the you don't, you negotiate as a corporate world but you don't negotiate as a individual helping to pay for it. host: erin you can take the last point. guest: this is a very acute example of what lawmakers are trying to work against. you know, and terms of obviously inflation it was a big concern for senator joe manchin.

again just the climbing costs and direct -- drug prices overall. so it's going to be interesting if they are able to accomplish this bill. how much impact it will have, how great -- far-reaching will the impact be? but certainly, this probably isn't the last word on capitol hill. host: kevin, pittsburgh, good morning. caller: good morning, how are you? host: caller: good morning. i'm calling about being diagnosed with syrup -- psoriasis. i'm 70 years old. i go to get the medicine, i worked on my life. i felt like someone and when he gets up to me, $2300 a month is what i take.

i mean, that seems to be a sin in this country if you want to be healthy be healthy. if you are for or middle-class you have to suffer you know all day long, and the medicine the logic in new medicine that is what they call it. in america, it's horrible. for should have never occurred. host: are you on medicare? caller: yes, i'm 70. host: and your out-of-pocket expenses are 2300? caller: yes and some are 5000. host: will address kim's situation? guest: one caveat because i don't have the numbers specific

to the situation but on the face of it it sounds like your out-of-pocket cap would impact your situation. i don't know much about the specific drugs you have to take the it will be interesting that they would arsenal to come under negotiation in the next couple of years. certainly, the out-of-pocket cap for two thousand dollars sounds like it would be useful here. host: what are senators, members of congress caring about on the feedback they are getting? if you are in -- on a fixed income it is still a lot of money every month. guest: well, considering this deal was struck last night, you know, i don't know what you are hearing individually. i have heard from advocates who have touted this provision is

being very helpful. but i think this is going to be very individual. you know, and this is also not taking into account any other kind of additional assistance someone might be able to get if they are lower income. so you always want to explain the caveat that we might not be able to be taking everything here. i certainly heard a statement over prescription, the disk christian -- description of the rebate. host: surely in houston, good morning. caller: i understand this is trained to help us but i want to make something very clear. if you go to canada and you check out one of the drugs that you are on, you pay probably have over what you pay here. i would say that our drug prices

here are higher. so we are paying for all of the research that is being done for the world. i mean, really. host: i want to take that point, charlotte. guest: that is actually one of the big arguments early on when there were more efforts to tie our crisis to other countries and canada camo with a lot. there is a discussion over the years of having drug invocation because of the drug costs. he really hit on a point on a hs happened a lot. it's not really being captured in this particular proposal moving right now. it is something that has been part of the discussion certainly.

host: erin durkin is a health care reporter for national journal. you can follow her work at national today members of congress will participate in their annual baseball game and washington d.c. live coverage from nationals park begins 7:00 p.m. eastern on c-span. you can watch on c-span now, free mobile video up or online at c-span.org. ♪♪ >> the world's first general-purpose electronic computer called any act was top-secret u.s. army project during world war ii that weighed 30 tons and took a 1800 square feet. sunday night on q&a, kathy and governance expert at american university college of law and author of proving ground talks about six american women who

programmed her efforts to get their work known to the larger public. >> of visionary of any act he works to build together, they were the team that left the construction and building the who were the women and what are they doing in the pictures? i wanted to know because if they did something technical i wanted to know because i could use the role models. i took the photograph to my professor, he sent me to the cofounder of the computer history museum and she told me they were models but they weren't in the captions because they were just posed, models. i didn't think that was right and i went looking for the people in the pictures and i found them and they want models, all six of the original programmers were young women

hired during world war ii. >> cap interval, proving ground. sunday night 8:00 p.m. eastern on c-span's q and a. you can listen to q&a and all of our podcasts and free c-span now app. ♪♪ >> free mobile app be drink on future view of what's happening live and on demand. keep up with the day's biggest events with live streams with hearings from u.s. congress. the world of politics. all at your fingertips. stay current with the leg episodes of "washington journal" and live scheduling information for c-span's tv networks c-span radio plus a variety of compelling podcasts. c-span now is available at the apple store and google play, download for free today c-span now, front row seat to washington anytime, anywhere. ♪♪ >> climate and energy professionals testify in the process capturing carbon dioxide emissions to combat